These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17052787)

  • 1. Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects.
    Miller M; Langenberg P; Havas S
    Int J Cardiol; 2007 Jul; 119(2):192-5. PubMed ID: 17052787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol.
    Toth PP; Zarotsky V; Sullivan JM; Laitinen D
    Curr Med Res Opin; 2009 Jun; 25(6):1355-63. PubMed ID: 19425901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lysine, vitamin B(6), and carnitine supplementation on the lipid profile of male patients with hypertriglyceridemia: a 12-week, open-label, randomized, placebo-controlled trial.
    Hlais S; Reslan DR; Sarieddine HK; Nasreddine L; Taan G; Azar S; Obeid OA
    Clin Ther; 2012 Aug; 34(8):1674-82. PubMed ID: 22818869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG
    Artery; 1992; 19(6):353-66. PubMed ID: 1471924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of triglycerides on other plasma lipids in middle-aged men intended for hypolipidaemic treatment.
    Kolovou GD; Anagnostopoulou KK; Salpea KD; Hoursalas IS; Petropoulos I; Bilianou HI; Damaskos DS; Giannakopoulou VN; Cokkinos DV
    Hellenic J Cardiol; 2006; 47(2):78-83. PubMed ID: 16752527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.
    Oelrich B; Dewell A; Gardner CD
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):350-7. PubMed ID: 21924882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states.
    Rashid S; Uffelman KD; Lewis GF
    J Diabetes Complications; 2002; 16(1):24-8. PubMed ID: 11872362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible risk factor for postmenopausal women: postprandial hypertriglyceridemia.
    Yoshikata R; Miyahara Y; Onoe Y; Okano H; Ohta H
    J Obstet Gynaecol Res; 2008 Dec; 34(6):1032-6. PubMed ID: 19012704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy.
    Masana L; Ibarretxe D; Heras M; Cabré A; Ferré R; Merino J; Plana N; Girona J
    Atherosclerosis; 2013 Feb; 226(2):471-5. PubMed ID: 23290265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
    Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
    J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.
    Goldenberg NM; Wang P; Glueck CJ
    Clin Chim Acta; 2003 Jun; 332(1-2):11-9. PubMed ID: 12763274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia.
    Kolovou GD; Anagnostopoulou K; Pilatis ND; Salpea KD; Hoursalas IS; Petropoulos I; Bilianou HI; Cokkinos DV
    Vasc Health Risk Manag; 2005; 1(2):155-61. PubMed ID: 17315402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.